Nuveen Asset Management, LLC Sesen Bio, Inc. Transaction History

Nuveen Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.89 $200,043 - $468,523	-526,431 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.73 - $1.28 $182,511 - $320,020	-250,016 Reduced 32.2%	526,431 $3.11 Million
Q3 2021 Nov 12, 2021	SELL	$0.77 - $4.91 $7,964 - $50,784	-10,343 Reduced 1.31%	776,447 $4.58 Million
Q2 2021 Aug 16, 2021	BUY	$2.18 - $4.66 $1.72 Million - $3.67 Million	786,790 New	786,790 $3.64 Million

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.